Tata Chemicals · NSE: TATACHEM · BSE: 500770

Q3 FY25 results · Oct–Dec 2024

Tata Chemicals reported revenue from operations of ₹3,590.00 crore (down 3.8% from Q3 FY24) and net loss of ₹21.00 crore for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.

Consolidated · ₹ crore
Item	Q3 FY25	Q3 FY24	YoY	Q2 FY25	QoQ
Revenue from operations	3,590.00	3,730.00	−3.8%	3,999.00	−10.2%
Other income	28.00	38.00	−26.3%	108.00	−74.1%
Total income	3,618.00	3,768.00	−4.0%	4,107.00	−11.9%
Profit before share of associates & JVs and tax	(36.00)	202.00	Turned loss	304.00	Turned loss
Share of profit/(loss) of associates & JVs	32.00	60.00		44.00
Net profit for the period	(21.00)	194.00	Turned loss	267.00	Turned loss
Attributable to shareholders of the company	(53.00)	158.00	Turned loss	194.00	Turned loss
EPS, basic (₹)	(2.08)	6.20	Turned loss	7.61	Turned loss
Net margin (%)	-0.6	5.2		6.7

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q3 FY25	Q3 FY24	YoY	Q2 FY25	QoQ
Revenue from operations	1,166.00	1,093.00	+6.7%	1,009.00	+15.6%
Other income	16.00	22.00	−27.3%	95.00	−83.2%
Total income	1,182.00	1,115.00	+6.0%	1,104.00	+7.1%
Profit before tax	83.00	140.00	−40.7%	117.00	−29.1%
Net profit for the period	72.00	115.00	−37.4%	99.00	−27.3%
EPS, basic (₹)	2.83	4.51	−37.3%	3.89	−27.2%
Net margin (%)	6.2	10.5		9.8

Consolidated

Filed with BSE: 03 Feb 2025, 19:59 IST
Board meeting: 03 Feb 2025
Period: 01 Oct 2024 to 31 Dec 2024
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 03 Feb 2025, 19:59 IST
Board meeting: 03 Feb 2025
Period: 01 Oct 2024 to 31 Dec 2024
Review status: Audited
Source: XBRL filing on BSE